搜索临床试验以:BP1001 结合 LDAC
总计1768个结果
-
Bio-Path Holdings, Inc.完全的复发性成人急性髓性白血病 | 急性淋巴细胞白血病 | 骨髓增生异常综合症 | Ph1 阳性 CML美国
-
National Cancer Institute (NCI)招聘中
-
CStone PharmaceuticalsBlueprint Medicines Corporation完全的
-
Hunan Province Tumor Hospital尚未招聘
-
Hunan Province Tumor Hospital尚未招聘
-
Second Affiliated Hospital of Nanchang University招聘中
-
West China HospitalSichuan Provincial People's Hospital; The First People's Hospital of Ziyang; Chengdu City No.2... 和其他合作者尚未招聘
-
Arvinas Androgen Receptor, Inc.主动,不招人
-
Atrial Fibrillation NetworkDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Preventicus GmbH; Corsano/ MMT; Getemed Medizin-...完全的
-
Association of Dutch Burn CentresSeventh Framework Programme; Ernst Reichmann Tissue Biology Research Unit, Zürich完全的
-
Association of Dutch Burn CentresSeventh Framework Programme; Ernst Reichmann Tissue Biology Research Unit, Zürich完全的
-
Jiangsu Yahong Meditech Co., Ltd aka Asieris招聘中
-
Leiden University Medical Center招聘中
-
Cytos Biotechnology AG完全的
-
Treace Medical Concepts, Inc.招聘中
-
Acerta Pharma BVAstraZeneca主动,不招人
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of Birmingham招聘中
-
Aarhus University HospitalVIA University College; Institute of public health, department of nursing sciences, Århus University...终止